Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]

View source ↗

Summary

Phase 3 multicenter, randomized, double-blind, placebo-controlled trial evaluating aripiprazole for acute manic or mixed episodes in bipolar I disorder; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-12